Finance Watch: Exscientia Launches Last IPO Of Q3, Brings US Total To 88
AI-Enabled Firm Raised $464.7m From IPO, Private Placement
Public Company Edition: Also, Roivant and two other biopharma firms close SPAC mergers and begin trading on the Nasdaq, Spero negotiated a royalty financing worth up to $125m and Phathom secured a $200m term loan.
